This company has been marked as potentially delisted and may not be actively trading. NASDAQ:VSCP (VSCP) (VSCP) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (VSCP) Stock (NASDAQ:VSCP) 30 days 90 days 365 days Advanced Chart Get (VSCP) alerts:Sign Up Key Stats Today's Range$4.04▼$4.0450-Day Range N/A52-Week Range$1.73▼$6.65VolumeN/AAverage Volume34,573 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVirtualScopics, Inc. is a provider of imaging services serving the pharmaceutical and biotechnology industries in early and late-stage clinical trials. The Company offers a range of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable reproducible measurement of minute changes that occur in anatomic structures in oncology, cardiology, neurology and musculoskeletal diseases. It has developed a system which enables the assessment of oncology patients per standard Response Evaluation Criteria in Solid Tumors criteria, while permitting the measurement of measures, including tumor volume, tumor metabolic rate through fluorodeoxyglucose-positron emission tomography and tumor mitotic rate through fluorodeoxyglucose-positron emission tomography or tumor cellular density through diffusion magnetic resonance imaging.Read More… Receive VSCP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (VSCP) and its competitors with MarketBeat's FREE daily newsletter. Email Address VSCP Stock News HeadlinesVesey Street Capital Partners Completes Corporate Carveout of ComplexCare SolutionsJanuary 13, 2025 | finance.yahoo.comSafecor Health Names Mark Saxon as New CEO to Lead Next Era of GrowthSeptember 26, 2024 | finance.yahoo.comNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.June 29 at 2:00 AM | American Alternative (Ad)Victoria SPorts overhauls cycling teamMarch 4, 2024 | msn.comYuneng Technology Co Ltd Class A 688348February 2, 2024 | morningstar.comMVesey Street Capital Partners Announces Majority Recapitalization of Inceptua GroupJanuary 16, 2024 | finance.yahoo.comFilming MpungweJanuary 9, 2024 | bbc.co.ukVesey Street Capital Partners Expands its Investment Team with New Partner, Chris HasslingerNovember 20, 2023 | finance.yahoo.comSee More Headlines VSCP Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (VSCP) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (VSCP) investors own include InterCloud Systems (ICLD), Acer Therapeutics (ACER), Novavax (NVAX), SELLAS Life Sciences Group (SLS), (UNISQ) (UNISQ) and Amarin (AMRN). Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:VSCP CIK1307752 Webwww.virtualscopics.com Phone+1-585-2496231FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:VSCP) was last updated on 6/29/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (VSCP) Please log in to your account or sign up in order to add this asset to your watchlist. Share (VSCP) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.